Загрузка...
PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma
PARP inhibitors are mostly effective as anticancer drugs in association with DNA damaging agents. We have previously shown that the oncolytic adenovirus dl922‐947 induces extensive DNA damage, therefore we hypothesized a synergistic antitumoral effect of the PARP inhibitor olaparib in association wi...
Сохранить в:
| Опубликовано в: : | Mol Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528680/ https://ncbi.nlm.nih.gov/pubmed/25139258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|